Background Data from subjective patient-reported outcome measures (PROMs) are now being used in the health sector to make or support decisions about individuals, groups and populations. Contemporary ...

BOSTON — Amgen Inc. and smaller rival Transkaryotic Therapies Inc. fought over the validity of patents on the top-selling anemia drug Epogen, as lawyers concluded arguments in a patent-infringement ...